Stryker (SYK) Net Cash Flow Growth (1y) (2010 - 2026)
Stryker (SYK) Net Cash Flow Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.52 Bn | 176.22 Bn | 6.27 Bn | -53.07% |
| 2 | Stryker | 128.83 Bn | 125.95 Bn | 3.81 Bn | 17.60% |
| 3 | Medtronic | 108.61 Bn | 99.39 Bn | 6.41 Bn | 10.50% |
| 4 | Boston Scientific | 68.35 Bn | 66.90 Bn | 3.61 Bn | -283.58% |
| 5 | Edwards Lifesciences | 48.53 Bn | 44.86 Bn | 1.29 Bn | -564.44% |
| 6 | Dexcom | 28.42 Bn | 27.30 Bn | 750.30 Mn | -31.84% |
| 7 | GE HealthCare Technologies | 28.34 Bn | 26.06 Bn | 1.98 Bn | -394.13% |
| 8 | Smith & Nephew | 26.92 Bn | 26.35 Bn | - | - |
| 9 | Koninklijke Philips | 25.49 Bn | 22.36 Bn | 2.07 Bn | 76.43% |
| 10 | Steris | 21.55 Bn | 21.11 Bn | 697.10 Mn | 57.36% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17.60% |
| Dec 31, 2025 | 548.80% |
| Sep 30, 2025 | -54.99% |
| Jun 30, 2025 | 104.00% |
| Mar 31, 2025 | -117.36% |
| Dec 31, 2024 | -115.23% |
| Sep 30, 2024 | 304.76% |
| Jun 30, 2024 | -80.00% |
| Mar 31, 2024 | -270.24% |
| Dec 31, 2023 | 175.95% |
| Sep 30, 2023 | 15.55% |
| Jun 30, 2023 | 33.51% |
| Mar 31, 2023 | 88.69% |
| Dec 31, 2022 | -0.75% |
| Sep 30, 2022 | 23.67% |
| Mar 31, 2022 | -113.20% |
| Dec 31, 2021 | 109.54% |
| Sep 30, 2021 | -34.75% |
| Mar 31, 2021 | -105.00% |
| Dec 31, 2020 | -275.37% |